Neurostimulation Devices Market Analysis - Global Industry Size, Share, Trends and Forecast 2022 - 2030
Neurostimulation provides pain relief by disrupting the pain signals traveling between the spinal cord and the brain. Neurostimulation technology can improve the life quality of those who are severely paralyzed or have profound losses to various sense organs. Rising chronic disorders is one of the primary reasons that have fueled the demand for neurostimulation devices market. Technological advancements in these devices are boosting the neurostimulation devices market revenue.
According to our neurostimulation devices industry analysis, the spinal cord stimulators generated the largest market revenue in 2021 and are likely to do so in the coming future. One of the primary reasons for the market's expansion is the emergence of regulations for spinal cord stimulation therapy. Several government organizations are working on developing guidelines for this therapy's use in the treatment of chronic pain and other disorder indications.
The application segment is divided into pain management, epilepsy, essential tremor, urinary and fecal incontinence, depression, dystonia, gastroparesis, parkinson’s disease. Among the application the pain management segment is expected to account for major revenue share in the global market. Epilepsy, on the other hand is likely to witness a significant growth rate during the projected timeframe from 2022 to 2030.CHAPTER 1. Industry Overview of Neurostimulation Devices Market
1.1. Definition and Scope
1.1.1. Definition of Neurostimulation Devices
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Neurostimulation Devices Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Neurostimulation Devices Market By Product
1.2.3. Neurostimulation Devices Market By Application
1.2.4. Neurostimulation Devices Market By End-Use
1.2.5. Neurostimulation Devices Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Neurostimulation Devices Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Neurostimulation Devices Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2021
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021
4.2. R&D Status of Major Manufacturers in 2021
CHAPTER 5. Neurostimulation Devices Market By Product
5.1. Introduction
5.2. Neurostimulation Devices Revenue By Product
5.2.1. Neurostimulation Devices Revenue (USD Million) and Forecast, By Product, 2018-2030
5.2.2. Spinal Cord Stimulators
5.2.2.1. Spinal Cord Stimulators Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3. Deep Brain Stimulators
5.2.3.1. Deep Brain Stimulators Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.4. Sacral Nerve Stimulators
5.2.4.1. Sacral Nerve Stimulators Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.5. Vagus Nerve Stimulators
5.2.5.1. Vagus Nerve Stimulators Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.6. Gastric Electric Stimulators
5.2.6.1. Gastric Electric Stimulators Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 6. Neurostimulation Devices Market By Application
6.1. Introduction
6.2. Neurostimulation Devices Revenue By Application
6.2.1. Neurostimulation Devices Revenue (USD Million) and Forecast, By Application, 2018-2030
6.2.2. Pain Management
6.2.2.1. Pain Management Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.3. Epilepsy
6.2.3.1. Epilepsy Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.4. Essential Tremor
6.2.4.1. Essential Tremor Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.5. Urinary and Fecal Incontinence
6.2.5.1. Urinary and Fecal Incontinence Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.6. Depression
6.2.6.1. Depression Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.7. Dystonia
6.2.7.1. Dystonia Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.8. Gastroparesis
6.2.8.1. Gastroparesis Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.9. Parkinson’s Disease
6.2.9.1. Parkinson’s Disease Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.10. Others
6.2.10.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 7. Neurostimulation Devices Market By End-Use
7.1. Introduction
7.2. Neurostimulation Devices Revenue By End-Use
7.2.1. Neurostimulation Devices Revenue (USD Million) and Forecast, By End-Use, 2018-2030
7.2.2. Hospitals
7.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2018-2030
7.2.3. Specialty Clinics
7.2.3.1. Specialty Clinics Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 8. North America Neurostimulation Devices Market By Country
8.1. North America Neurostimulation Devices Market Overview
8.2. U.S.
8.2.1. U.S. Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
8.2.2. U.S. Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
8.2.3. U.S. Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
8.3. Canada
8.3.1. Canada Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
8.3.2. Canada Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
8.3.3. Canada Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
8.4. North America PEST Analysis
CHAPTER 9. Europe Neurostimulation Devices Market By Country
9.1. Europe Neurostimulation Devices Market Overview
9.2. U.K.
9.2.1. U.K. Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
9.2.2. U.K. Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
9.2.3. U.K. Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.3. Germany
9.3.1. Germany Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
9.3.2. Germany Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
9.3.3. Germany Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.4. France
9.4.1. France Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
9.4.2. France Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
9.4.3. France Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.5. Spain
9.5.1. Spain Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
9.5.2. Spain Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
9.5.3. Spain Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.6. Rest of Europe
9.6.1. Rest of Europe Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
9.6.2. Rest of Europe Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
9.6.3. Rest of Europe Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Neurostimulation Devices Market By Country
10.1. Asia Pacific Neurostimulation Devices Market Overview
10.2. China
10.2.1. China Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
10.2.2. China Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
10.2.3. China Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
10.3. Japan
10.3.1. Japan Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
10.3.2. Japan Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
10.3.3. Japan Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
10.4. India
10.4.1. India Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
10.4.2. India Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
10.4.3. India Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
10.5. Australia
10.5.1. Australia Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
10.5.2. Australia Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
10.5.3. Australia Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
10.6. South Korea
10.6.1. South Korea Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
10.6.2. South Korea Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
10.6.3. South Korea Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
10.7.2. Rest of Asia-Pacific Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
10.7.3. Rest of Asia-Pacific Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Neurostimulation Devices Market By Country
11.1. Latin America Neurostimulation Devices Market Overview
11.2. Brazil
11.2.1. Brazil Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
11.2.2. Brazil Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
11.2.3. Brazil Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
11.3. Mexico
11.3.1. Mexico Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
11.3.2. Mexico Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
11.3.3. Mexico Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
11.4. Rest of Latin America
11.4.1. Rest of Latin America Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
11.4.2. Rest of Latin America Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
11.4.3. Rest of Latin America Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Neurostimulation Devices Market By Country
12.1. Middle East & Africa Neurostimulation Devices Market Overview
12.2. GCC
12.2.1. GCC Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
12.2.2. GCC Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
12.2.3. GCC Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
12.3. South Africa
12.3.1. South Africa Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
12.3.2. South Africa Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
12.3.3. South Africa Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Neurostimulation Devices Revenue (USD Million) and Forecast By Product, 2018-2030
12.4.2. Rest of Middle East & Africa Neurostimulation Devices Revenue (USD Million) and Forecast By Application, 2018-2030
12.4.3. Rest of Middle East & Africa Neurostimulation Devices Revenue (USD Million) and Forecast By End-Use, 2018-2030
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Neurostimulation Devices Market
13.1. Neurostimulation Devices Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Neurostimulation Devices Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Boston Scientific Corporation
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Million), 2021
14.1.3.2. Boston Scientific Corporation 2021 Neurostimulation Devices Business Regional Distribution
14.1.4. Product/Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Medtronic
14.3. St. Jude Medical
14.4. Bayer AG
14.5. Cyberonics, Inc
14.6. IntraPace Inc.
14.7. Neuronetics
14.8. Nevro Corp.
14.9. Uroplasty, Inc
14.10. ImThera Medical, Inc.
14.11. NeuroPace, Inc.
Frequently Asked Questions
How much was the size of the global neurostimulation devices market in 2021?
The global neurostimulation devices market size in 2021 was accounted to be USD 6,141 Million.
What will be the projected CAGR for global Neurostimulation Devices market during forecast period of 2022 to 2030?
The projected CAGR neurostimulation devices market during the analysis period of 2022 to 2030 is 11.3%.
Which are the prominent competitors operating in the market?
The prominent players of the global neurostimulation devices market are Boston Scientific Corporation, Medtronic, St. Jude Medical, Bayer AG, Cyberonics, Inc, IntraPace Inc., Neuronetics, Nevro Corp., Uroplasty, Inc., ImThera Medical, Inc., and NeuroPace, Inc.
Which region held the dominating position in the global Neurostimulation Devices market?
North America held the dominating neurostimulation devices during the analysis period of 2022 to 2030.
Which region exhibited the fastest growing CAGR for the forecast period of 2022 to 2030?
Asia-Pacific region exhibited fastest growing CAGR for neurostimulation devices during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global Neurostimulation Devices market?
Growing prevalence of neurological disorders and nerve injuries worldwide, rising demand for minimally invasive surgeries, and growing base of geriatric patients with neurological disorders drives the growth of global neurostimulation devices market.
By product segment, which sub-segment held the maximum share?
Based on product, spinal cord stimulators segment held the maximum share neurostimulation devices market in 2021.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
